Merck’s KEYTRUDA demonstrates extended relief for patients with resected stage IIB and IIC melanoma
New results build on previously reported significant recurrence-free survival (rfs) benefit seen in these patients
New results build on previously reported significant recurrence-free survival (rfs) benefit seen in these patients
Women's health is in fact a direct reflection of the nation's overall health
First advanced hybrid closed-loop insulin pump system in India features automatic insulin delivery, automatic correction boluses, and bluetooth connectivity
Taisho Pharmaceutical will bring its experience and expertise in the research and development of therapeutic products to the collaboration.
The approval marks the first-and-only immunotherapy-based treatment for use before surgery for non-small cell lung cancer
The large-scale production of PhytoChol in Hanau, Germany, will meet an increased market demand for cholesterol
Collaboration aims to capture patient-to-patient variability to determine the best treatment for every cancer
Novel delivery of established growth and neurotrophic factors enables local, sustained release for greater efficacy
Ovarian cancer is one of the most difficult cancers to treat. It is typically not detected until later stages, and about 70 percent of patients will have recurrence after an initial treatment, which is often fatal
Viralex is an immunomodulatory agent with broad-spectrum antiviral properties. It enhances both innate & adaptive immunity and strengthens the body's defence response to viral infections
Subscribe To Our Newsletter & Stay Updated